Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Leontien Kremer

Principal Investigator
--
Phone 088 97 290 000

 --

  • Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines

    • dec. 2022
    • Esmée C., de Baat, et al
    • The Lancet Child and Adolescent Health
  • Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries

    • nov. 2022
    • Rebecca J., Van Kalsbeek, et al
    • BMJ Open
  • Cohort profile

    • nov. 2022
    • Yuehan, Wang, et al
    • BMJ Open
  • Expert survey on coverage and characteristics of pediatric palliative care in Europe – a focus on home care

    • okt. 2022
    • Julia, Wager, et al
    • BMC Palliative Care
  • Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines

    • sep. 2022
    • Esmée C., de Baat, et al
    • Cochrane Database of Systematic Reviews
View all publications